CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) |
3 Months Ended | 6 Months Ended | 9 Months Ended | 12 Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2024 |
Jun. 30, 2024 |
Mar. 31, 2024 |
Sep. 30, 2023 |
Jun. 30, 2023 |
Mar. 31, 2023 |
Jun. 30, 2024 |
Jun. 30, 2023 |
Sep. 30, 2024 |
Sep. 30, 2023 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Revenues | ||||||||||||
| Total revenues | $ 3,354,437 | $ 1,620,995 | $ 1,432,721 | $ 1,271,473 | $ 1,577,518 | $ 3,332,561 | $ 2,848,991 | $ 6,686,998 | $ 4,281,712 | $ 10,421,352 | $ 5,765,889 | |
| Cost of revenues | 569,734 | $ 934,570 | 1,320,823 | 1,890,557 | 3,243,772 | 1,933,195 | ||||||
| Gross margin | 2,784,703 | 776,996 | 1,234,742 | 954,322 | 797,186 | 1,002,196 | 2,011,738 | 1,799,382 | 4,796,441 | 2,753,704 | 7,177,580 | 3,832,694 |
| Operating expenses | ||||||||||||
| Compensation and related benefits | 1,730,369 | 912,743 | 1,806,320 | 3,536,689 | 5,306,458 | 4,417,028 | ||||||
| General and administrative expenses | 2,218,289 | 568,469 | 210,767 | 284,834 | 386,346 | 341,213 | 779,236 | 727,559 | 2,997,525 | 1,012,393 | 6,553,961 | 1,202,456 |
| Goodwill impairment charges | 56,675,210 | 56,675,210 | 56,675,210 | |||||||||
| Transaction expenses | 455,834 | 228,307 | 254,645 | 710,479 | 792,796 | 86,799 | ||||||
| Total operating expenses | 61,079,702 | 1,709,519 | 1,130,682 | 1,307,388 | 1,487,023 | 1,718,051 | 2,840,201 | 3,205,074 | 63,919,903 | 4,512,462 | 69,328,425 | 5,706,283 |
| Net operating loss | (58,294,999) | (932,523) | 104,060 | (353,066) | (689,837) | (715,855) | (828,463) | (1,405,692) | (59,123,462) | (1,758,758) | (62,150,845) | (1,873,589) |
| Other income (expense) | ||||||||||||
| Interest expense | (115,385) | (341,835) | (351,145) | (466,530) | (211,459) | (191,323) | ||||||
| Other income (expense), net | 504 | (20,114) | ||||||||||
| Change in fair value of financial instruments | 6,176,097 | 90,200 | ||||||||||
| Loss on issuance of financial instruments | (595,000) | (2,213,234) | (2,513,234) | |||||||||
| Loss on extinguishment of debt | (645,979) | (645,979) | (645,979) | |||||||||
| Change in fair value on embedded derivative | 90,200 | |||||||||||
| Gain on forgiveness of debt | 107,862 | |||||||||||
| Total other income (expense), net | 4,381,240 | (1,411,967) | (1,421,277) | 2,959,963 | 2,805,929 | (13,375) | ||||||
| Loss before benefit from (provision for) income taxes | (53,913,759) | (2,344,490) | 94,750 | (411,007) | (681,686) | (717,572) | (2,249,740) | (1,399,258) | (56,163,499) | (1,810,265) | (59,344,916) | (1,886,964) |
| Benefit from (provision for) income taxes | (8,802) | 1,678,388 | 1,678,388 | 1,669,586 | 1,642,901 | (1,838,490) | ||||||
| Net loss | (53,922,561) | (666,102) | 94,750 | (177,291) | (507,291) | (534,729) | (571,352) | (1,042,020) | (54,493,913) | (1,219,311) | (57,702,015) | (3,725,454) |
| Net profit attributable to non-controlling interest | 37,476 | |||||||||||
| Net loss attributable to stockholders | $ (53,922,561) | $ (634,122) | $ 62,770 | $ (189,756) | $ (503,320) | $ (529,962) | $ (571,352) | $ (1,033,282) | $ (54,493,913) | $ (1,223,038) | $ (57,702,015) | $ (3,762,930) |
| Basic loss per common share (in dollars per share) | $ (3.58) | $ (0.12) | $ 0.01 | $ (0.02) | $ (0.11) | $ (0.05) | $ (0.11) | $ (0.22) | $ (6.53) | $ (0.12) | $ (5.65) | $ (0.38) |
| Diluted loss per common share (in dollars per share) | $ (3.58) | $ 0.01 | $ (0.02) | $ (0.11) | $ (0.05) | $ (0.11) | $ (0.22) | $ (6.53) | $ (0.12) | $ (5.65) | $ (0.38) | |
| Weighted average number of common shares outstanding, basic (in shares) | 10,213,036 | 9,998,446 | ||||||||||
| Weighted average number of common shares outstanding, diluted (in shares) | 10,213,036 | 9,998,446 | ||||||||||
| Subscription fees | ||||||||||||
| Revenues | ||||||||||||
| Total revenues | $ 4,115,126 | $ 4,044,807 | ||||||||||
| Professional services and other fees | ||||||||||||
| Revenues | ||||||||||||
| Total revenues | 2,108,307 | 1,063,114 | ||||||||||
| Technical engineering fees | ||||||||||||
| Revenues | ||||||||||||
| Total revenues | $ 806,456 | $ 287,950 | $ 201,228 | $ 29,900 | $ 156,937 | $ 477,889 | $ 186,837 | $ 1,284,345 | $ 388,065 | 1,980,186 | $ 657,968 | |
| Patient fees | ||||||||||||
| Revenues | ||||||||||||
| Total revenues | 1,207,343 | |||||||||||
| Telehealth fees | ||||||||||||
| Revenues | ||||||||||||
| Total revenues | 1,003,510 | |||||||||||
| Institutional fees | ||||||||||||
| Revenues | ||||||||||||
| Total revenues | $ 6,880 | |||||||||||
| X | ||||||||||
- Definition This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Net Increase or Decrease in the fair value of the embedded derivative or group of embedded derivatives included in earnings in the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of expense for employee benefit and equity-based compensation. No definition available.
|
| X | ||||||||||
- Definition Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as nonoperating. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of financial instruments. No definition available.
|
| X | ||||||||||
- Definition Amount of increase (decrease) in the fair value of financial instruments at issuance recognized in the income statement. No definition available.
|
| X | ||||||||||
- Definition Amount of gain on decrease for amounts of indebtedness forgiven by the holder of the debt instrument. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|